Compare EBS & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBS | BYND |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 413.3M | 352.7M |
| IPO Year | 2006 | 2018 |
| Metric | EBS | BYND |
|---|---|---|
| Price | $8.28 | $0.71 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 7 |
| Target Price | ★ $12.00 | $0.83 |
| AVG Volume (30 Days) | 930.3K | ★ 34.3M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.83 | 24.69 |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $742,900,000.00 | $275,496,000.00 |
| Revenue This Year | $1.29 | N/A |
| Revenue Next Year | N/A | $1.36 |
| P/E Ratio | $118.29 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.62 | $0.50 |
| 52 Week High | $14.06 | $7.69 |
| Indicator | EBS | BYND |
|---|---|---|
| Relative Strength Index (RSI) | 49.90 | 47.11 |
| Support Level | $7.77 | $0.67 |
| Resistance Level | $8.54 | $0.73 |
| Average True Range (ATR) | 0.42 | 0.05 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 66.67 | 40.47 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.